Atlas Trials

SARS-CoV-2 Donor-Recipient Immunity Transfer

Clinical trial NCT04666025 · COMPLETED

Trial details

NCT number
NCT04666025
Sponsor
City of Hope Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Phase CML, BCR-ABL1 PositiveCOVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmHodgkin LymphomaLymphoblastic LymphomaMyelodysplastic SyndromeMyelofibrosisMyeloproliferative Neoplasm
Start date
2020-09-23
Primary completion
2023-05-05
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.